BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26996829)

  • 1. Impact of human T-cell leukemia virus type 1 on living donor liver transplantation: a multi-center study in Japan.
    Yoshizumi T; Takada Y; Shirabe K; Kaido T; Hidaka M; Honda M; Ito T; Shinoda M; Ohdan H; Kawagishi N; Sugawara Y; Ogura Y; Kasahara M; Kubo S; Taketomi A; Yamashita N; Uemoto S; Yamaue H; Miyazaki M; Takada T; Maehara Y
    J Hepatobiliary Pancreat Sci; 2016 Jun; 23(6):333-41. PubMed ID: 26996829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of human T cell leukemia virus type 1 in living donor liver transplantation.
    Yoshizumi T; Shirabe K; Ikegami T; Kayashima H; Yamashita N; Morita K; Masuda T; Hashimoto N; Taketomi A; Soejima Y; Maehara Y
    Am J Transplant; 2012 Jun; 12(6):1479-85. PubMed ID: 22486853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation.
    Kawano N; Shimoda K; Ishikawa F; Taketomi A; Yoshizumi T; Shimoda S; Yoshida S; Uozumi K; Suzuki S; Maehara Y; Harada M
    Transplantation; 2006 Sep; 82(6):840-3. PubMed ID: 17006333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-cell leukemia virus type 1 infection worsens prognosis of hepatitis C virus-related living donor liver transplantation.
    Ichikawa T; Taura N; Miyaaki H; Matsuzaki T; Ohtani M; Eguchi S; Takatsuki M; Soyama A; Hidaka M; Okudaira S; Usui T; Mori S; Kamihira S; Kanematsu T; Nakao K
    Transpl Int; 2012 Apr; 25(4):433-8. PubMed ID: 22417010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of elderly donors for liver transplantation: A single-center experience.
    Kamo N; Kaido T; Hammad A; Ogawa K; Fujimoto Y; Uemura T; Mori A; Hatano E; Okajima H; Uemoto S
    Liver Transpl; 2015 May; 21(5):591-8. PubMed ID: 25641778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of HTLV-I-positive renal transplant recipients.
    Nakamura N; Tamaru S; Ohshima K; Tanaka M; Arakaki Y; Miyauchi T
    Transplant Proc; 2005 May; 37(4):1779-82. PubMed ID: 15919464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.
    Kawano N; Yoshida S; Kawano S; Kuriyama T; Tahara Y; Toyofuku A; Manabe T; Doi A; Terasaka S; Yamashita K; Ueda Y; Ochiai H; Marutsuka K; Yamano Y; Shimoda K; Kikuchi I
    J Clin Exp Hematop; 2018 Sep; 58(3):107-121. PubMed ID: 30089749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor.
    González-Pérez MP; Muñoz-Juárez L; Cárdenas FC; Zarranz Imirizaldu JJ; Carranceja JC; García-Saiz A
    Transplantation; 2003 Apr; 75(7):1006-11. PubMed ID: 12698089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation for acute liver failure: are there thresholds not to be crossed?
    Hoyer DP; Munteanu M; Canbay A; Hartmann M; Gallinat A; Paul A; Saner FH
    Transpl Int; 2014 Jun; 27(6):625-33. PubMed ID: 24606197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult T-cell leukemia in a liver transplant recipient that did not progress after onset of graft rejection.
    Suzuki S; Uozumi K; Maeda M; Yamasuji Y; Hashimoto S; Komorizono Y; Owatari S; Tokunaga M; Haraguchi K; Arima N
    Int J Hematol; 2006 Jun; 83(5):429-32. PubMed ID: 16787875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-to-adult living-donor liver transplantation: The experience of the Université catholique de Louvain.
    Iesari S; Inostroza Núñez ME; Rico Juri JM; Ciccarelli O; Bonaccorsi-Riani E; Coubeau L; Laterre PF; Goffette P; De Reyck C; Lengelé B; Gianello P; Lerut J
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):132-142. PubMed ID: 30850341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan.
    Arisaw K; Katamine S; Kamihira S; Kurokawa K; Sawada T; Soda M; Doi H; Saito H; Shirahama S
    Cancer Causes Control; 2002 Sep; 13(7):657-63. PubMed ID: 12296513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: a prospective cohort study.
    Arisawa K; Sobue T; Yoshimi I; Soda M; Shirahama S; Doi H; Katamine S; Saito H; Urata M
    Cancer Causes Control; 2003 Nov; 14(9):889-96. PubMed ID: 14682446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors.
    O'Brien SF; Goldman M; Scalia V; Yi QL; Fan W; Xi G; Dines IR; Fearon MA
    Transfus Med; 2013 Oct; 23(5):358-66. PubMed ID: 23859527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of HTLV-1 positive renal transplant recipients in Iran.
    Naghibi O; Nazemian F; Naghibi M; Ali Javidi DB
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):670-4. PubMed ID: 21743209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
    Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M;
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.